Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Cancers
|
March 29, 2023
Immunotherapy for Solid Tumors
Hortense de Saint Basile, Zineb Maaradji, Elizabeth Fabre
Cancer Drug Resistance (Alhambra, Calif.)
|
May 18, 2022
Biomarkers of resistance to immune checkpoint inhibitors in non-small-cell lung cancer: myth or reality?
Ivan Pourmir, Benoit Gazeau, Hortense de Saint Basile, et al.
Exploration of Targeted Anti-Tumor Therapy
|
January 7, 2025
Analysis of the benefit of anti-PD-1 monotherapy according to NGS-diagnosed genetic alterations in patients with non-small cell lung cancer
Hortense De Saint Basile, Reza Elaidi, Zineb Maaradji, et al.
Cancers
|
December 9, 2023
Longitudinal Study of Advanced Non-Small Cell Lung Cancer with Initial Durable Clinical Benefit to Immunotherapy: Strategies for Anti-PD-1/PD-L1 Continuation beyond Progression
Ivan Pourmir, Reza Elaidi, Zineb Maaradji, et al.
Journal for Immunotherapy of Cancer
|
December 4, 2024
Differential predictive value of resident memory CD8<sup>+</sup>T cell subpopulations in patients with non-small-cell lung cancer treated by immunotherapy
Léa Paolini, Thi Tran, Stéphanie Corgnac, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 16, 2023
RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion
Mihaela Aldea, Arianna Marinello, Michael Duruisseaux, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Cancers
|
March 29, 2023
Immunotherapy for Solid Tumors
Hortense de Saint Basile, Zineb Maaradji, Elizabeth Fabre
Cancer Drug Resistance (Alhambra, Calif.)
|
May 18, 2022
Biomarkers of resistance to immune checkpoint inhibitors in non-small-cell lung cancer: myth or reality?
Ivan Pourmir, Benoit Gazeau, Hortense de Saint Basile, et al.
Exploration of Targeted Anti-Tumor Therapy
|
January 7, 2025
Analysis of the benefit of anti-PD-1 monotherapy according to NGS-diagnosed genetic alterations in patients with non-small cell lung cancer
Hortense De Saint Basile, Reza Elaidi, Zineb Maaradji, et al.
Cancers
|
December 9, 2023
Longitudinal Study of Advanced Non-Small Cell Lung Cancer with Initial Durable Clinical Benefit to Immunotherapy: Strategies for Anti-PD-1/PD-L1 Continuation beyond Progression
Ivan Pourmir, Reza Elaidi, Zineb Maaradji, et al.
Journal for Immunotherapy of Cancer
|
December 4, 2024
Differential predictive value of resident memory CD8<sup>+</sup>T cell subpopulations in patients with non-small-cell lung cancer treated by immunotherapy
Léa Paolini, Thi Tran, Stéphanie Corgnac, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 16, 2023
RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion
Mihaela Aldea, Arianna Marinello, Michael Duruisseaux, et al.
Page
of 1